AD/PD 2023
Related
Together we advance neuroscience research
Your insights. Our technologies. Let’s move neuroscience research forward together.
We use insights from the most pioneering neuroscientists in the world – our customers – to develop the tools needed to advance the cutting edge of neuroscience research.
Venue: Gothia Towers, Gothenburg, Sweden
Exhibit hall dates: Tuesday, March 28th- Saturday, April 1, 2023
Booth #: 39
The AD/PD™ Conference has become the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD™ is now an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.
abcam’s expertise supports the creation of high-quality products that meet our global customers’ complex research requirements, including high-throughput immunoassays, neuroscience reagents, and custom antibodies. We partner with our customers, listening closely to their needs, to produce unique, tailor-made solutions.
Abcam is proud to exhibit and participate at AD/PD 2023 . For additional information on our conference participation or to schedule a meeting with our attending Abcam experts, please email Abcam Events Team.
Explore new ways to light up your research
Get to the root cause of neurodegeneration with a comprehensive range of neuroinflammation research tools to detect glia, aggregated proteins and proinflammatory mediators in Alzheimer's and Parkinson's diseases. Check out interactive pathways, webinars, protocol videos & resources.
- Neuroinflammation and Alzheimer's disease poster
- Neuroinflammation in neurodegenerative diseases guide
- Multiple Sclerosis | Professor Gavin Giovannoni
- Huntingon's disease treatment | Professor Roger Barker
- The Micheal J. Fox Foundation on Parkinson's Disease | abcam
- Immunoassay: FirePlex®-HT | abcam
- The role of astrocytes in neurodegenerative disease | Assistant Professor Shane Liddelow